Role of MTHFR C677T and MTR A2756G polymorphisms in thyroid and breast cancer development

Autor(es)

Zara-Lopes, T. ; Gimenez-Martins, A. P. A. ; Nascimento-Filho, C. H. V. ; Castanhole-Nunes, M. M. U. ; Galbiatti-Dias, A. L. S. ; Padovani-Junior, J. A. ; Maniglia, J. V. ; Francisco, J. L. E. ; Pavarino, E. C. ; Goloni-Bertollo, E. M.

• Tipo de documento: Artigo Científico
• Fonte: Genetics and Molecular Research; v. 15, n. 2 2016.
• Citações Web of Science: 8

Resumo

Folate metabolism is essential for DNA synthesis and repair. Alterations in genes that participate in folate metabolism can be associated with several types of malignant neoplasms, including thyroid and breast cancer. In the present case-control study, we examined the association between methylenetetrahydrofolate reductase (MTHFR C677T, rs1801133) and methionine synthase (MTR A2756G, rs1805087) polymorphisms and risk for thyroid and breast cancer. Polymerase chain reaction-restriction fragment length technique was used to determine the specific genotypes in the genes of interest. Statistical analysis was performed by multiple logistic regression test. We found an association between MTHFR C677T polymorphism and risks to both thyroid (OR = 2.50; 95% CI = 1.15-5.46; P = 0.02) and breast cancer (OR = 2.53; 95% CI = 1.08-5.93; P = 0.03). Tobacco consumption and high body mass index were also associated with thyroid cancer. In addition, increased age (= 50 years) and alcohol consumption were found to be associated with breast cancer. Our results indicated that MTHFR C677T is significantly associated with thyroid and breast cancer risks. Thus, these factors may be used as potential prognostic markers for thyroid and breast cancers. (AU)

• Processo FAPESP: 12/14781-1 - Avaliação dos polimorfismos de genes metabolizadores de xenobióticos (GSTM1, GSTT1, GSTP1 e mEH) em pacientes com cirrose e carcinoma hepatocelular
• Beneficiário: Eny Maria Goloni Bertollo
• Linha de fomento: Auxílio à Pesquisa - Regular
• Processo FAPESP: 10/12930-4 - Avaliação de quimioterápicos, expressão gênica e quantificação de proteínas em carcinoma de cabeça e pescoço
• Beneficiário: Eny Maria Goloni Bertollo
• Linha de fomento: Auxílio à Pesquisa - Regular